Menopause Treatment Market Overview
The menopause treatment market is likely to record a healthy CAGR of over 6.18% over the assessment period from 2020 to 2027. The market is projected to acquire a market size of approximately USD 15,456.3 Million by 2027.
Menopause is a natural process with treatments that focus on symptomatic relief. Vaginal dryness is treated with estrogen or topical lubricants. Medications can lessen the frequency and severity of hot flushes. The global menopause treatment market has been witnessing massive growth in recent times. The extensive R&D activities are driving the market's growth to launch novel drugs, rising menopausal symptoms, growing disposable income of women, and availability of herbal treatment for menopause. However, the market's growth is likely to be restricted by the low awareness, low-income levels, considerable gender-wise health disparities, and lack of advanced healthcare infrastructure.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4579
Segment Analysis
The global menopause treatment market is divided into several segments based on treatment, distribution channel, and region.
Based on treatment, the menopause treatment market is split into anti-depressants, hormonal treatment, non-hormonal treatment, estrogen, combination, progesterone, and others.
The menopause treatment market is bifurcated into online stores, retail pharmacies, and hospital pharmacies based on the distribution channels.
Regional Analysis
The menopause treatment market is studied across four major regions, including the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The American regional market for menopause treatment dominated the market globally in 2019. The well-established healthcare industry is driving the regional market's growth with modern infrastructure, new drug launches, and the growth in urogenital complications and vasomotor symptoms among women. Furthermore, the rising introduction of novel drugs, high prevalence of an unhealthy lifestyle, increased awareness, supportive government initiatives, and the constantly growing female population aged over 60 are also likely to boost the regional market's growth.
The Asia-Pacific regional market for menopause treatment is likely to register the highest growth over the review timeframe. The regional market's growth is attributed to the rising instances of players entering joint ventures with the local firms and the mounting awareness level about women's health. Furthermore, the growing technological literacy and growth in the working women population are projected to accelerate the regional menopause treatment market over the review timeframe.
Competitive Analysis
The global menopause treatment market has an intensely competitive landscape. The growing R&D activities and therapies for menopause are likely to encourage new players to join the market. The players across the market are adopting several new strategies such as expansions, collaborations, joint ventures, acquisitions, and FDA approvals. The list of leading players in the menopause treatment market includes companies such as Novo Nordisk A/S (Denmark), Cipla Inc. (India), Abbott Laboratories (U.S.), Pfizer Inc. (U.S.), Merck & Co. Inc. (U.S.), Allergan (Ireland), Teva Pharmaceuticals (Israel), Eli Lily and Company (U.S.), Novartis AG (Switzerland), Emcure Pharmaceuticals Ltd (India), and many others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579
Recent Developments
- December 2021 – a leader in women's health innovation, Daré Bioscience, Inc., announced that XACIATO [zah-she-AH-toe] got approval from the U.S. Food and Drug Administration (FDA) to treat bacterial vaginosis in females 12 years of age and older.
- December 2021 – a leading real-world evidence company, Syapse®, devoted to extinguishing the fear and burden of severe diseases by progressing real-world care, presented five abstracts at the leading global conference for health economics and outcomes research (HEOR), Virtual ISPOR Europe 2021. Chief commercial officer at Syapse, David Pomerantz said that the company is proud to have a strong presence and to be sharing such crucial work at this year's Virtual ISPOR Europe meeting.
Browse Related Reports at:
Global Dental Chair Market Research Report—Forecast till 2027
Global Neurorehabilitation Devices Market Research Report—Forecast till 2027
Global Hyperspectral Imaging System Market Research Report—Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment